This study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome whose seizures are not controlled by medication. The device detects and responds to seizure activity in the brain to reduce drop seizures. The goal is to see if…
Phase: PHASE2 • Sponsor: NeuroPace • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC